Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line...

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Adult T-cell leukemia (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1).
• ATL cells exhibit resistance to conventional chemotherapy.
• There is a critical need for novel therapeutic agents targeting HTLV-1-infected T cells.

Purpose of the Study:

• To investigate the efficacy of roscovitine, a cyclin-dependent kinase (CDK) inhibitor, in inducing apoptosis in HTLV-1-transformed T cells.
• To elucidate the molecular mechanisms underlying roscovitine's anti-leukemic effects.
• To explore the role of signal transducer and activator of transcription 5 (STAT5) and platelet-derived growth factor (PDGF) alpha receptors in HTLV-1-driven leukemogenesis.

Main Methods:

• Treatment of HTLV-1-transformed MT-2 T-cell line with roscovitine.
• Assessment of apoptosis induction and cell viability.
• Analysis of STAT5 phosphorylation and activation.
• Investigation of STAT5 interaction with the XIAP promoter.
• Co-precipitation assays using antibodies against PDGF alpha receptors.
• Evaluation of the effect of sodium orthovanadate on roscovitine's actions.

Main Results:

• Roscovitine induced apoptosis in the MT-2 T-cell line.
• Roscovitine inhibited STAT5 tyrosine phosphorylation and activation, independent of caspase-3.
• Ectopic expression of dominant-negative STAT5 also induced apoptosis.
• Roscovitine and dominant-negative STAT5 reduced XIAP expression, with STAT5 binding to the XIAP promoter.
• STAT5 co-precipitated with PDGF alpha receptors in untreated cells, but not in roscovitine-treated cells.
• Sodium orthovanadate reversed roscovitine's inhibitory effects on STAT5/PDGF alpha receptor interaction, STAT5 activity, and cell survival.

Conclusions:

• Roscovitine effectively induces apoptosis in HTLV-1-transformed T cells.
• The mechanism involves the inhibition of STAT5 activation, potentially through reduced tyrosine phosphorylation of PDGF alpha receptors.
• This pathway leads to decreased expression of the anti-apoptotic protein XIAP, promoting cell death.
• Roscovitine represents a promising therapeutic candidate for adult T-cell leukemia.